Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines

被引:17
|
作者
Wang, Hee Ryung [1 ]
Bahk, Won-Myong [1 ]
Seo, Jeang Seok [2 ]
Woo, Young Sup [1 ]
Park, Young -Min [3 ]
Jeong, Jong-Hyun [4 ]
Kim, Won [5 ,6 ]
Shim, Se-Hoon [7 ]
Lee, Jung Goo [8 ,9 ,10 ]
Jon, Duk-In [11 ]
Min, Kyung Joon [12 ]
机构
[1] Catholic Univ Korea, Dept Psychiat, Coll Med, Seoul, South Korea
[2] Konkuk Univ, Dept Psychiat, Sch Med, Chungju, South Korea
[3] Inje Univ, Coll Med, Dept Psychiat, Ilsan Paik Hosp, Goyang, South Korea
[4] Catholic Univ Korea, St Vincents Hosp, Dept Psychiat, Coll Med, Suwon, South Korea
[5] Inje Univ, Sch Med, Dept Psychiat, Seoul Paik Hosp, Seoul, South Korea
[6] Inje Univ, Stress Res Inst, Seoul, South Korea
[7] Soonchunhyang Univ, Dept Psychiat, Coll Med, Cheonan Hosp, Cheonan, South Korea
[8] Inje Univ, Dept Psychiat, Coll Med, Haeundae Paik Hosp, Busan, South Korea
[9] Inje Univ, Palk Inst Clin Res, Busan, South Korea
[10] Inje Univ, Dept Hlth Sci & Technol, Grad Sch, Busan, South Korea
[11] Hallym Univ, Sacred Heart Hosp, Dept Psychiat, Coll Med, Anyang, South Korea
[12] Chung Ang Univ, Dept Psychiat, Coll Med, Seoul, South Korea
关键词
Depressive disorder; Expert consensus; Guideline; KMAP DD 2017; Therapy; PSYCHIATRY WFSBP GUIDELINES; 2016 CLINICAL GUIDELINES; BIOLOGICAL TREATMENT; CANADIAN NETWORK; WORLD FEDERATION; MOOD; MANAGEMENT; SOCIETIES; ADULTS; LEVOMILNACIPRAN;
D O I
10.9758/cpn.2017.15.3.199
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
In this review, we compared recommendations from the Korean Medication Algorithm Project for Depressive Disorder 2017 (KMAP DD 2017) to other global treatment guidelines for depression. Six global treatment guidelines were reviewed; among the six, 4 were evidence based guidelines, 1 was an expert consensus based guideline, and 1 was an amalgamation of both evidence and expert consensus based recommendations. The recommendations in the KMAP DD 2017 were generally similar to those in other global treatment guidelines, although there were some differences between the guidelines. The KMAP DD 2017 appeared to reflect current changes in the psychopharmacology of depression quite well, like other recently published evidence based guidelines. As an expert consensus based guideline, the KMAP DD 2017 had some limitations. However, considering there are situations in which clinical evidence cannot be drawn from planned clinical trials, the KMAP DD 2017 may be,helpful for Korean psychiatrists making decisions in the clinical settings by complementing previously published evidence based guidelines.
引用
收藏
页码:199 / 209
页数:11
相关论文
共 50 条
  • [31] Efficacy of Antidepressant Medication in the Treatment of Major Depressive Disorder
    Anderson, Benjamin
    Muller, Andrew
    ARCHIVES OF CLINICAL PSYCHIATRY, 2023, 50 (01) : 123 - 129
  • [32] Korean Medication Algorithm Project for Bipolar Disorder 2022: Treatment Strategy According to Safety and Tolerability
    Park, S. Y.
    Bahk, W. -M.
    Woo, Y. S.
    Jon, D. -I.
    Kim, M. -D.
    Sohn, I.
    EUROPEAN PSYCHIATRY, 2024, 67 : S588 - S589
  • [33] A feasibility study of the Korean medication algorithm project for bipolar disorder: Choice of medications and treatment response
    Shin, Young Chul
    Jon, Duk-In
    Yoon, Bo-Hyun
    Cho, Hyun-Sang
    Min, Kyung Joon
    Kim, Chan-Hyung
    Ha, Kyoo-Seob
    Kwon, Jun Soo
    Bahk, Won-Myong
    BIPOLAR DISORDERS, 2006, 8 : 39 - 39
  • [34] Minocycline in Major Depressive Disorder: And overview with considerations on treatment-resistance and comparisons with other psychiatric disorders
    Nettis, Maria Antonietta
    BRAIN, BEHAVIOR, & IMMUNITY - HEALTH, 2021, 17
  • [35] The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD): Changes in Preferred Treatment Strategies and Medications over 20 Years and Five Editions
    Jang, Seung-Ho
    Bahk, Won-Myong
    Woo, Young Sup
    Seo, Jeong Seok
    Park, Young-Min
    Kim, Won
    Jeong, Jong-Hyun
    Shim, Se-Hoon
    Lee, Jung Goo
    Jon, Duk-In
    Min, Kyung Joon
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [36] Updated CANMAT Guidelines for Treatment of Major Depressive Disorder
    Patten, Scott B.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2016, 61 (09): : 504 - +
  • [37] Suicidal ideation and other persisting symptoms after CBT or antidepressant medication treatment for major depressive disorder
    Dunlop, Boadie W.
    Polychroniou, Philip E.
    Rakofsky, Jeffrey J.
    Nemeroff, Charles B.
    Craighead, W. Edward
    Mayberg, Helen S.
    PSYCHOLOGICAL MEDICINE, 2019, 49 (11) : 1869 - 1878
  • [38] Florida Best Practice Psychotherapeutic Medication Guidelines for Adults With Major Depressive Disorder
    McIntyre, Roger S.
    Suppes, Trisha
    Tandon, Rajiv
    Ostacher, Michael
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (06) : 703 - 713
  • [39] Duloxetine in the treatment of major depressive disorder: Comparisons of safety and efficacy
    Bailey, RK
    Mallinckrodt, CH
    Wohlreich, MM
    Watkin, JG
    Plewes, JM
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2006, 98 (03) : 437 - 447
  • [40] Korean medication algorithm project for bipolar disorder 2014: Rapid cycling
    Jeong, J. -H.
    Jae, Y. M.
    Jon, D. -I.
    Bahk, W. -M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2014, 17 : 92 - 92